About the Company
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SRRA News
Sierra Oncology Inc. (SRRA)
Investor Bill Ackman said the new omicron variant of the coronavirus could actually give U.S. stocks a boost if symptoms turn out to be less severe. The latest 13F reporting period has come and ...
Sierra Oncology (NASDAQ: SRRA)
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to ...
GSK bolsters cancer pipeline with $1.9bn Sierra Oncology buy
GlaxoSmithKline has agreed a deal to buy Sierra Oncology and its lead drug momelotinib for anaemia associated with the blood cancer myelofibrosis, sending the US biotech's shares skywards.
MSU vaccine-tech spinoff hopes it can make lightning strike again
Don Parfet is hoping he can experience some deja vu all over again, to use a phrase coined by that great microbiologist Yogi ...
Patrick G Enright's Net Worth
Who is Patrick G Enright? Patrick G Enright has an estimated net worth of $1.94 Billion. This is based on reported shares across multiple companies, which include VALENTIS INC, Inozyme Pharma, Inc ...
Champions Oncology, Inc. (CSBR)
HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions ...
IKNA Ikena Oncology, Inc.
Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the ...
Oncology Pharma Inc ONPH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
CRDF Cardiff Oncology, Inc.
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like ...
Champions Oncology, Inc.
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft ...
Loading the latest forecasts...